Ignite Creation Date:
2025-12-24 @ 12:17 PM
Ignite Modification Date:
2026-04-16 @ 7:13 AM
Study NCT ID:
NCT05730361
Status:
UNKNOWN
Last Update Posted:
2023-02-15
First Post:
2023-02-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase Ib Clinical Study on the Safety, the Tolerability, the Pharmacokinetics and the Efficacy of ScTIL Injection (Gene Modified Tumor Infiltrating Lymphocytes) Alone and in Combination With B Lymphocyte Adjuvant in the Treatment of Digestive System Malignant Solid Tumors
Sponsor:
Peking University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ScTIL-B-009-2022
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None